- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Jackson Square Capital LLC Boosts Eli Lilly and Company Holdings
Investment firm increases stake in pharmaceutical giant by over 25%
Apr. 12, 2026 at 9:39am
Got story updates? Submit your updates here. ›
Institutional investors see opportunity in the complex machinery and processes that power Eli Lilly's pharmaceutical innovation.Indianapolis TodayJackson Square Capital LLC, an investment management firm, has increased its position in Eli Lilly and Company (NYSE: LLY) by 26.6% in the fourth quarter. The firm now owns 18,437 shares of the pharmaceutical company's stock, valued at $19.81 million, making it one of the firm's top holdings.
Why it matters
Eli Lilly is a major player in the pharmaceutical industry, known for its innovative drugs and therapies. The increase in Jackson Square Capital's stake suggests the firm sees strong growth potential in the company, which could signal positive sentiment among institutional investors.
The details
According to a recent SEC filing, Jackson Square Capital LLC purchased an additional 3,875 shares of Eli Lilly and Company during the fourth quarter, bringing its total holdings to 18,437 shares. This investment now makes up approximately 3.9% of the firm's overall portfolio.
- Jackson Square Capital LLC increased its Eli Lilly and Company holdings in the fourth quarter of 2025.
The players
Jackson Square Capital LLC
An investment management firm that has increased its stake in Eli Lilly and Company.
Eli Lilly and Company
A global pharmaceutical company known for its innovative drugs and therapies.
The takeaway
The increase in Jackson Square Capital's position in Eli Lilly and Company suggests the investment firm sees strong growth potential in the pharmaceutical giant, which could signal positive sentiment among institutional investors about the company's future prospects.
